CU6 2.71% $7.20 clarity pharmaceuticals ltd

Ann: First patient treated in theranostic prostate cancer trial, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3 Posts.
    Not sure that for patients waiting around for an hour with the current testing regime is a big deal. I have done it twice and would prefer to having to return to the testing centre the next day. I thought a potentially significant advantage of CU6's technology is that it remains effective significantly longer so a more centralised manufacturing and distribution model is possible as compared with, say Telix's product.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$7.20
Change
0.190(2.71%)
Mkt cap ! $2.305B
Open High Low Value Volume
$7.12 $7.34 $6.95 $5.698M 788.1K

Buyers (Bids)

No. Vol. Price($)
4 16776 $7.20
 

Sellers (Offers)

Price($) Vol. No.
$7.27 197 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.